Zhihua is an experienced drug hunter and a proven executive leader in pharmaceutical R&D. Zhihua built winning teams in both big pharma and biotech. His teams discovered and advanced more than 20 compounds into clinical stage for oncology, rare genetic diseases, reproductive/urology disorders (men’s and women’s health), inflammation and metabolic diseases. Zhihua has extensive experience in drug discovery platforms such as SBDD, FBDD and mechanism-based designs as well as protein degradation. He is a co-author or co-inventor on more than 300 publications in peer-reviewed journals, invited lectures and patents. Zhihua is also experienced in external collaboration with academic/industrial organizations, in diligence of external assets and in outsourcing management.
Zhihua Sui is an experienced drug hunter and executive leader in pharmaceutical R&D with over 32 years of work experience. He has a strong background in drug discovery, medicinal chemistry, and oncology. Zhihua has built winning teams in both big pharma and biotech, gaining expertise in oncology, rare genetic diseases, reproductive/urology disorders, inflammation, and metabolic diseases. He is also a co-author and co-inventor of over 300 publications and has experience in external collaboration with academic/industrial organizations. Zhihua has held various leadership positions in renowned companies such as Proteovant Therapeutics, Ensem Therapeutics, NJ Bio, Inc.,
The name ENSEM connotes innovations in integrating groundbreaking technologies to decipher structural ENSEMbles and kinetics for drug design. ENSEM is a pioneering drug discovery and development company that leverages its unique Kinetic Ensemble™ platform to develop innovative small molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas. ENSEM integrates computational and AI deep learning methodologies with advanced experimental techniques to identify non-obvious binding pockets and accelerate structure-based drug design, with a focus on high-value and difficult-to-drug targets
Princeton,New Jersey,United States
NJ Bio Inc. Is a CRO that provides integrated chemistry and biology services to clients from the biotech and pharma sectors. Main service areas include antibody drug conjugates, nucleotide and oligonucleotide synthesis, multi-step organic synthesis, PROTAC and flow chemistry based process development. The company is headquartered in the in the Princeton, New Jersey with additional chemistry facilities in Bristol, PA. NJ Bio has Amar Chemistry Pvt. Ltd. As an exclusive partner in India for flow chemistry services as well as chemical process R&D.
We're focused on discovering and developing novel investigational medicines to treat genetically defined diseases through scientific leadership in the field of cellular metabolism. Our most advanced drug candidate is a first-in-class pyruvate kinase R (PKR) activator, mitapivat, that is currently being evaluated for the treatment of three distinct hemolytic anemias. In addition to our active late-stage clinical pipeline, we have multiple novel, investigational therapies in clinical and preclinical development. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results.
Raritan,New Jersey,United States
At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Arterial Hypertension. Visit us: www.janssen.com Follow us: @JanssenGlobal on Twitter and Instagram Watch our videos on our YouTube channel: http://bit.ly/1LY2xQ5
San Francisco,California,United States
We found 3 Zhihua Sui's email addresses
We found 1 Zhihua Sui's phone numbers
Zhihua Sui's social media include: Linkedin,
Zhihua Sui works for Proteovant Therapeutics
Zhihua Sui's role in Proteovant Therapeutics is Chief Scientific Officer
Zhihua Sui works in the industry of
Zhihua Sui's colleagues are
Zhihua Sui's latest job experience is Chief Scientific Officer at Proteovant Therapeutics
Zhihua Sui's latest education in Heidelberg University